Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Leprosy is an infectious disease that remains hyperendemic in several Brazilian regions. Patient contacts face a higher risk for infection and illness, which can subsequently contribute to the persistence of the disease.

Objective: This study investigates the risk factors associated with anti-phenolic glycolipid-I (anti-PGL-I) seropositivity and leprosy development among contacts of leprosy patients in a highly endemic region.

Methods: A cohort of 629 contacts from the Almenara microregion, Minas Gerais, Brazil, was followed from 1998 to 2018. Our research group assessed risk factors, including sociodemographic determinants, bacillus exposure, and genetic susceptibility.

Findings: Analysis revealed that living with a multibacillary (MB) leprosy patient [odds ratio (OR): 3.01, 95% confidence interval (CI): 1.02-8.86] and with a patient with grade II disabilities (OR: 4.43, 95% CI: 1.08-18.1) significantly increased the likelihood of anti-PGL-I seropositivity among asymptomatic contacts. Risk factors for leprosy included living with a patient in a shared residence (OR: 2.84, 95% CI: 1.21-6.67) and blood relation to the patient (OR: 2.56, 95% CI: 1.18-5.54). Notably, 98% of contacts who developed leprosy had lived with more than one patient.

Main Conclusions: Clinical characteristics of index patients play a critical role in infection risk among contacts. Leprosy progression appears to depend on genetic susceptibility, type of contact, and extent of bacillus exposure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12113343PMC
http://dx.doi.org/10.1590/0074-02760240061DOI Listing

Publication Analysis

Top Keywords

anti-pgl-i seropositivity
12
risk factors
12
leprosy
8
sociodemographic determinants
8
genetic susceptibility
8
contacts leprosy
8
bacillus exposure
8
contacts
7
patient
5
risk
5

Similar Publications

Background: Leprosy is an infectious disease that remains hyperendemic in several Brazilian regions. Patient contacts face a higher risk for infection and illness, which can subsequently contribute to the persistence of the disease.

Objective: This study investigates the risk factors associated with anti-phenolic glycolipid-I (anti-PGL-I) seropositivity and leprosy development among contacts of leprosy patients in a highly endemic region.

View Article and Find Full Text PDF

A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil.

Eur J Clin Microbiol Infect Dis

April 2025

Rapid Test Development and Production Laboratory, Institute of Tropical Pathology and Public Health, Federal University of Goiás, LDPTR/IPTSP/UFG), Goiânia, GO, 74605-050, Brazil.

Purpose: Leprosy represents a public health concern; its diagnosis remains clinical. Recently, the Brazilian public health system/SUS incorporated the leprosy-specific IgM anti-PGL-I rapid test Fast ML Flow Hanseníase (MLFH/Bioclin, Brazil; originally ML Flow) to aid leprosy contacts surveillance and diagnosis. Anti-PGL-I antibody levels correlate with bacterial load.

View Article and Find Full Text PDF

Background: Detection of infection with Mycobacterium leprae allows timely prophylactic treatment, thereby reducing transmission as well as the risk of permanent, leprosy-associated nerve damage. However, since there is no worldwide-implemented standard test for M. leprae infection, detection of infection in asymptomatic individuals remains a major challenge for control programs in endemic areas.

View Article and Find Full Text PDF

Leprosy is a chronic, debilitating disease lacking a definitive diagnostic biomarker. Serum anti-phenolic glycolipid-I (PGL-I) IgM antibody level is considered an important diagnostic and prognostic marker for leprosy patients. However, there is limited evidence on the role of anti-PGL-I IgM antibody level as early predictive biomarker of subclinical infection among Egyptian household contacts of leprosy patients.

View Article and Find Full Text PDF
Article Synopsis
  • IgM antibodies against phenolic glycolipid I (PGL-I) are important for indicating past infections and the prevalence of leprosy in a population, but they cannot differentiate between recent and past infections.
  • Researchers conducted a serosurvey in leprosy-endemic villages in Bihar, India, using a simple fingerstick blood test to assess anti-PGL-I IgM levels among children aged 3-11 years.
  • The results showed an 11.58% seroprevalence, suggesting a consistent infection rate compared to other areas, highlighting the test's potential as a practical tool for monitoring recent leprosy transmission in children as part of eradication efforts.
View Article and Find Full Text PDF